Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer

European Journal of Cancer

Volumn 46, Issue 18, 2010, Pages 3205-3210

  Aukema, Tjeerd S ^a   Straver, Marieke E ^a   Peeters, Marie Jeanne T F D Vrancken ^a   Russell, Nicola S ^a   Gilhuijs, Kenneth G A ^a   Vogel, Wouter V ^a   Rutgers, Emiel J T ^a   Olmos, Renato A Valdés ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Breast neoplasms; Extra axillary lymph nodes; Neoplasm staging; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; FEMALE; HUMAN; INTERNAL MAMMARY ARTERY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDIASTINUM LYMPH NODE; NEEDLE BIOPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; ULTRASOUND;

ADULT; AGED; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS;

EID: 78649629411     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.07.034     Document Type: Article

References (29)

1. S.H. Estourgie, O.E. Nieweg, R.A. Olmos, E.J. Rutgers, and B.B. Kroon Lymphatic drainage patterns from the breast Ann Surg 239 2004 232 237
2. R.F. Uren, R. Howman-Giles, S.B. Renwick, and D. Gillett Lymphatic mapping of the breast: locating the sentinel lymph nodes World J Surg 25 2001 789 793
3. M.C. van Rijk, P.J. Tanis, and O.E. Nieweg Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer J Surg Oncol 94 15 2006 281 286
4. S.E. Singletary, and F.L. Greene Revision of breast cancer staging: the 6th edition of the TNM Classification Semin Surg Oncol 21 1 2003 53 59
5. A. Gil-Rendo, G. Zornoza, and M.J. Garcia-Velloso Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer Brit J Surg 93 6 2006 707 712
6. D. Fuster, J. Duch, and P. Paredes Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures J Clin Oncol 26 29 2008 4746 4751
7. J.J. van der Hoeven, O.S. Hoekstra, and E.F. Comans Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer Ann Surg 236 5 2002 619 624
8. I.C. Smith, K.N. Ogston, and P. Whitford Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-d-glucose Ann Surg 228 2 1998 220 227
9. E. Barranger, D. Grahek, and M. Antoine Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer Ann Surg Oncol 10 6 2003 622 627
10. P.J. Lovrics, V. Chen, and G. Coates A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer Ann Surg Oncol 11 9 2004 846 853
11. G. Zornoza, M.J. Garcia-Velloso, and J. Sola 18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer Eur J Surg Oncol 30 1 2004 15 19
12. U. Veronesi, C. De Cicco, and V.E. Galimberti A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases Ann Oncol 18 3 2007 473 478
13. T.F. Cermik, A. Mavi, S. Basu, and A. Alavi Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer Eur J Nucl Med Mol Imaging 35 3 2008 475 483
14. D.N. Danforth Jr., L. Aloj, and J.A. Carrasquillo The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer Breast Cancer Res Treat 75 2 2002 135 146
15. A. Tran, B.S. Pio, and B. Khatibi 18F-FDG PET for staging breast cancer in patients with inner-quadrant versus outer-quadrant tumors: comparison with long-term clinical outcome J Nucl Med 46 9 2005 1455 1459
16. J. Hannemann, H.M. Oosterkamp, and C.A. Bosch Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer J Clin Oncol 23 15 2005 3331 3342
17. S.L. Sugg, D.J. Ferguson, M.C. Posner, and R. Heimann Should internal mammary nodes be sampled in the sentinel lymph node era? Ann Surg Oncol 7 3 2000 188 192
18. L.A. Newman, H.M. Kuerer, and B. Fornage Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer Am J Surg 181 4 2001 313 318
19. R.A. Brito, V. Valero, and A.U. Buzdar Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas MD Anderson Cancer Center experience J Clin Oncol 19 3 2001 628 633
20. B. Farrus, S. Vidal-Sicart, and M. Velasco Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan Int J Radiat Oncol Biol Phys 60 3 2004 715 721
21. E. Madsen, P. Gobardhan, and V. Bongers The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer Ann Surg Oncol 14 4 2007 1486 1492
22. Frasci G, D'Aiuto G, Comella P, et al. Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908. Ann Oncol 2009;(October 8).
23. E.H. Huang, S.L. Tucker, and E.A. Strom Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy J Clin Oncol 22 23 2004 4691 4699
24. J.N. Ingle, D. Tu, and J.L. Pater Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial Breast Cancer Res Treat 99 3 2006 295 300
25. S.M. Stemmer, S. Rizel, and I. Hardan The role of irradiation of the internal mammary lymph nodes in high-risk stage II to IIIA breast cancer patients after high-dose chemotherapy: a prospective sequential nonrandomized study J Clin Oncol 21 14 2003 2713 2718
26. Romestaing P, Belot A, Hennequin C, et al. Ten-year results of a randomized trial of internal mammary chain irradiation after mastectomy. Int J Radiat Oncol Biol Phys 2009;75(3, Supplement 1):S1.
27. J.R. Bellon, R.B. Livingston, and W.B. Eubank Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC) Am J Clin Oncol 27 4 2004 407 410
28. W.B. Eubank, D.A. Mankoff, and J. Takasugi 18Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer J Clin Oncol 19 15 2001 3516 3523
29. M.E. Straver, T.S. Aukema, and R.A. Olmos Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients Eur J Nucl Med Mol Imaging 37 6 2010 1069 1076